1,896
Views
3
CrossRef citations to date
0
Altmetric
Operations Engineering & Analytics

Multi-model Markov decision processes

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1124-1139 | Received 10 Jan 2020, Accepted 24 Jan 2021, Published online: 10 May 2021

References

  • Ahmed, A., Varakantham, P., Lowalekar, M., Adulyasak, Y. and Jaillet, P. (2017) Sampling based approaches for minimizing regret in uncertain Markov decision processes (MDPs). Journal of Artificial Intelligence Research, 59, 229–264.
  • Alagoz, O., Maillart, L.M., Schaefer, A.J. and Roberts, M.S. (2007) Determining the acceptance of cadaveric livers using an implicit model of the waiting list. Operations Research, 55(1), 24–36.
  • Arias, E. and Xu, J. (2011) National vital statistics reports United States life tables, 2007. Statistics, 59(9), 1–132.
  • Ayer, T., Alagoz, O. and Stout, N.K. (2012) OR Forum - a POMDP approach to personalize mammography screening decisions. Operations Research, 60(5), 1019–1034.
  • Bertsimas, D., Silberholz, J. and Trikalinos, T. (2018) Optimal healthcare decision making under multiple mathematical models: Application in prostate cancer screening. Health Care Management Science, 21(1), 105–118.
  • Birge, J.R. and Louveaux, F. (2011) Introduction to Stochastic Programming, Springer, New York, NY.
  • Boucherie, R.J. and van Dijk, N.M. (eds) (2017) Markov Decision Processes in Practice. Cham, Switzerland: Springer.
  • Buchholz, P. and Scheftelowitsch, D. (2019) Computation of weighted sums of rewards for concurrent MDPs. Mathematical Methods of Operations Research, 89(1), 1–42.
  • Centers for Disease Control and Prevention (2011) National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States. Technical report, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
  • Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. and Roccella, E.J. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42(6), 1206–1252.
  • Craig, B.A. and Sendi, P.P. (2002) Estimation of the transition matrix of a discrete-time Markov chain. Health Economics, 11(1), 33–42.
  • Denton, B.T., Kurt, M., Shah, N.D., Bryant, S.C. and Smith, S.A. (2009) Optimizing the start time of statin therapy for patients with diabetes. Medical Decision Making, 29(3),351–367.
  • Etzioni, R., Gulati, R., Tsodikov, A., Wever, E.M., Penson, D.F., Heijnsdijk, E.A., Katcher, J., Draisma, G., Feuer, E.J., de Koning, H.J. and Mariotto, A.B. (2012) The prostate cancer conundrum revisited: Treatment changes and prostate cancer mortality declines. Cancer, 118(23), 5955–5963.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285(19), 2486–2497.
  • Goff, D.C., Lloyd-Jones, D.M., Bennett, G., Coady, S., D’Agostino, R.B., Gibbons, R., Greenland, P., Lackland, D.T., Levy, D., O’Donnell, C.J., Robinson, J.G., Schwartz, J.S., Shero, S.T., Smith, S.C., Sorlie, P., Stone, N.J. and Wilson, P.W.F. (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation, 129, S49–S73.
  • Gold, M.R., Stevenson, D. and Fryback, D.G. (2002) HALYs and QALYs and DALYs, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health, 23(1), 115–134.
  • Habbema, J.D.F., Schechter, C.B., Cronin, K.A., Clarke, L.D. and Feuer, E.J. (2006) Chapter 16: Modeling cancer natural history, epidemiology, and control: Reflections on the CISNET Breast Group experience. JNCI Monographs, 2006(36),122–126.
  • Le Tallec, Y. (2007) Robust, risk-sensitive, and data-driven control of Markov decision processes. Ph.D. thesis, Massachusetts Institute of Technology, Cambridge, MA.
  • Mandelblatt, Jeanne, S., et al. (2016) Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies. Annals of internal medicine, 164(4), 215–225.
  • Mannor, S., Simester, D., Peng, S. and Tsitsiklis, J.N. (2007) Bias and variance approximation in value function estimates. Management Science, 53(2), 308–322.
  • Mason, J.E., Denton, B.T., Shah, N.D. and Smith, S.A. (2014) Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients. European Journal of Operational Research, 233(3), 727–738.
  • Meraklı, M. and Küçükyavuz, S. (2020) Risk aversion to parameter uncertainty in Markov decision processes with an application to slow-onset disaster relief. IISE Transactions, 52(8), 811–831.
  • Mount Hood 4 Modeling Group. (2007) Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting. Diabetes Care, 30(6), 1638–1646.
  • Puterman, M.L. (2014) Markov Decision Processes: Discrete Stochastic Dynamic Programming, John Wiley & Sons, Hoboken, NJ.
  • Saghafian, S. (2018) Ambiguous partially observable Markov decision processes: Structural results and applications. Journal of Economic Theory, 178, 1–35.
  • Shechter, S.M., Bailey, M.D., Schaefer, A.J. and Roberts, M.S. (2008) The optimal time to initiate HIV therapy under ordered health states. Operations Research, 56(1), 20–33.
  • Singh, S.P., Tommi, J. and Jordan, M.I. (1994) Learning without state-estimation in partially observable Markovian decision processes. Proceedings of the Eleventh International Conference on Machine Learning 1994, Morgan Kaufmann, 1994, pp. 284–292. San Francisco, CA, USA.
  • Steimle, L.N., Ahluwalia, V.S., Kamdar, C. and Denton, B.T. (2021) Decomposition methods for solving Markov decision processes with multiple models of the parameters. IISE Transactions, 1–37.
  • Steimle, L.N. and Denton, B.T. (2017) Markov decision processes for screening and treatment of chronic diseases, in Markov Decision Processes in Practice, Springer, New York, NY. https://doi.org/10.1080/24725854.2020.1869351
  • Vijan. S. and Hayward, R.A. (2004) Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: Background paper for the American College of Physicians. Annals of Internal Medicine, 140(8), 650–658.
  • Vlassis, N., Littman, M.L. and Barber, D. (2012) On the computational complexity of stochastic controller optimization in POMDPs. ACM Transactions on Computation Theory, 4(4), 1–8.
  • Wilson, P.W.F., D’Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H. and Kannel, W.B. (1998) Prediction of coronary heart disease using risk factor categories. Circulation, 97(18),1837–1847.
  • Wolf, P.A., D’Agostino, R.B., Belanger, A.J. and Kannel, W.B. (1991) Probability of stroke: A risk profile from the Framingham Study. Stroke, 22(3), 312–318.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.